Oregon Merges Cannabis and Psilocybin Regulators Amid Budget Crisis

Fiscal Pressures Drive Administrative Consolidation

Oregon's cannabis and psilocybin oversight agencies will merge to address budget deficits that have strained both programs since 2024. The OLCC, which oversees the state's recreational cannabis market, and OPS, which administers the psilocybin therapy framework under Measure 109, have each reported declining fee revenue as licensing volumes plateau and compliance costs rise. Under a strict reading of the state's enabling statutes, both agencies operate as self-funded entities dependent on application fees, renewal fees, and per-transaction assessments.

The merger will consolidate back-office functions. Legal counsel, IT infrastructure, and field inspection teams all get folded together. Administrative redundancy has been a recurring complaint from licensees who navigate parallel application processes for cannabis and psilocybin facilities.

Revenue Shortfalls in Both Programs

Cannabis tax collections in Oregon have declined 18% year-over-year through Q2 2026, while psilocybin service center applications have fallen short of initial projections. The OLCC collected $102.3 million in cannabis taxes in fiscal 2025, down from $124.7 million in fiscal 2024, according to state revenue reports. Oversupply, interstate diversion, and persistent illicit competition have eroded margins for licensed operators.

OPS has licensed only 37 psilocybin service centers statewide since the program launched in June 2023. That's well below the 80-100 facilities the agency projected in its 2022 budget forecast. Lower-than-expected application volume has left OPS with a structural deficit, forcing the agency to draw down reserve funds to cover inspector salaries and rulemaking costs.

Regulatory Framework Remains Intact

The merger doesn't alter the substantive rules governing cannabis or psilocybin licensure, testing, or distribution. Oregon Revised Statutes Chapter 475B (cannabis) and Chapter 475A (psilocybin) will remain in force. The consolidated agency will maintain separate licensing tracks and compliance protocols for each substance class.

The consolidation is administrative, not regulatory—operators will see no change to testing thresholds, packaging requirements, or tax obligations under the current statutory framework.

Industry observers note that the merger may accelerate rulemaking harmonization in areas where cannabis and psilocybin regulations overlap, such as facility security standards and product-testing laboratory accreditation.

Implications for Dual-License Operators

Operators holding both cannabis and psilocybin licenses may benefit from streamlined renewals and unified inspection schedules. Approximately 11 Oregon businesses currently operate licensed cannabis retail locations and psilocybin service centers under separate corporate entities. Those operators have reported duplicative compliance burdens: separate annual inspections, parallel record-keeping systems, and non-overlapping continuing-education requirements for staff.

The merged agency is expected to pilot a single renewal portal for dual-license holders by Q3 2027. For more context on Oregon's evolving regulatory picture, see the CannIntel topic hub on Oregon cannabis regulation.

Federal Tax Treatment Unchanged

IRC §280E continues to apply to both cannabis and psilocybin businesses, regardless of the state-level merger. Neither program qualifies for federal tax deductions on ordinary business expenses under current IRS guidance. Oregon's state-level consolidation doesn't affect federal tax obligations or the applicability of cost-of-goods-sold accounting under Treasury Regulation 1.471-3.

Operators in both sectors remain subject to the same federal tax burden that has compressed margins across state-legal psychoactive markets.

What to Watch

The legislature will need to authorize the merger through enabling legislation in the 2027 session. Industry groups are expected to lobby for reciprocal licensing provisions that would allow psilocybin facilitators to cross-train as cannabis compliance officers, and vice versa. The next signal: draft legislation by September 2026.